Nord-Trøndelag Hospital Trust, Levanger, Norway.
Faculty of Nursing and Health Sciences, Nord University, Levanger, Norway.
BMJ Open. 2020 May 17;10(5):e035507. doi: 10.1136/bmjopen-2019-035507.
Compared to women with normotensive pregnancies, women with a history of pre-eclampsia have a roughly fourfold increased risk of developing chronic arterial hypertension and a twofold increased risk of developing cardiovascular disease (CVD). Lifestyle changes, such as increased physical activity, weight loss, smoking cessation and healthy diet, are effective for CVD prevention in the general population. However, no scoping review or systematic review of postpartum lifestyle interventions among women with pre-eclampsia have, to our best knowledge, been performed. The objective of this scoping review is to provide an overview of the available research literature on postpartum lifestyle interventions to reduce the risk of CVD among women with pre-eclampsia.
The protocol is based on the framework outlined by Arksey and O'Malley. Databases to be searched include: PubMed, Embase CINAHL and the JBI Database of Systematic Reviews and Implementation Reports. The search will be performed after the publication of this protocol (estimated to be 1 June 2020) and will be repeated 1 month prior to the submission for publication of the final review (estimated to be 1 January 2021). The review will consider studies that include women in the postpartum period (in particular, but not restricted to, the first 12 months after delivery), with a history of pre-eclampsia. Data will be extracted by two independent reviewers using a data extraction tool including specific details about the population, concept, context, study methods and key findings relevant to the review objective. Any disagreements between the reviewers will be resolved through discussion, or with a third reviewer. The extracted data will be presented in diagrammatic or tabular form that align with the objective of this scoping review. A narrative summary will accompany the tabulated and/or charted results and will describe how the results relate to the reviews objective and questions.
Since all data will be obtained from publicly available materials, the proposed scoping review does not require ethical approval. The results will be submitted for publication in an open-access peer-reviewed journal and presented at relevant conferences.
与血压正常的孕妇相比,有先兆子痫病史的女性发生慢性动脉高血压的风险约增加 4 倍,发生心血管疾病(CVD)的风险增加 2 倍。生活方式的改变,如增加体力活动、减肥、戒烟和健康饮食,对普通人群预防 CVD 是有效的。然而,据我们所知,目前还没有对先兆子痫患者产后生活方式干预的系统评价或范围界定审查。本范围界定审查的目的是提供关于产后生活方式干预以降低先兆子痫妇女 CVD 风险的现有研究文献综述。
该方案基于 Arksey 和 O'Malley 概述的框架。待搜索的数据库包括:PubMed、Embase、CINAHL 和 JBI 系统评价和实施报告数据库。搜索将在本方案发布后进行(估计为 2020 年 6 月 1 日),并在提交最终审查以供出版前 1 个月重复(估计为 2021 年 1 月 1 日)。该审查将考虑包括产后妇女(特别是但不限于分娩后 12 个月内)、有先兆子痫病史的研究。两名独立评审员将使用数据提取工具提取数据,该工具包括与审查目标相关的人群、概念、背景、研究方法和关键发现的具体细节。评审员之间的任何分歧将通过讨论或第三名评审员解决。提取的数据将以图表或表格形式呈现,与范围界定审查的目标一致。表格和/或图表结果将附有叙述性摘要,并描述结果与审查目标和问题的关系。
由于所有数据都将从公开可用的材料中获得,因此拟议的范围界定审查不需要伦理批准。研究结果将提交给开放获取的同行评审期刊发表,并在相关会议上展示。